Filing Details

Accession Number:
0001181431-12-012793
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-29 09:27:45
Reporting Period:
2012-02-27
Filing Date:
2012-02-29
Accepted Time:
2012-02-29 09:27:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
911326 Synageva Biopharma Corp GEVA Biological Products, (No Disgnostic Substances) (2836) 561808663
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532217 Chris Heberlig Synageva Biopharma Corp.
128 Spring St Ste 520
Lexington MA 02421
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2012-02-27 4,500 $0.95 4,500 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2012-02-27 4,500 $36.88 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-02-27 4,500 $0.00 12,377 $0.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,877 2019-07-01 No 4 M Direct
Footnotes
  1. The sale of Common Stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 8, 2011.
  2. The Stock Option granted the reporting person an option to purchase 12,377 shares Common Stock (the "Shares"). 25% of the Shares vested and became exercisable on 07/20/2010, and 1/36 of the remainder of the Shares vest and become exercisable monthly thereafter.